ATE73996T1 - Verwendung lang- und mittelkettiger triglyzeride. - Google Patents

Verwendung lang- und mittelkettiger triglyzeride.

Info

Publication number
ATE73996T1
ATE73996T1 AT85901182T AT85901182T ATE73996T1 AT E73996 T1 ATE73996 T1 AT E73996T1 AT 85901182 T AT85901182 T AT 85901182T AT 85901182 T AT85901182 T AT 85901182T AT E73996 T1 ATE73996 T1 AT E73996T1
Authority
AT
Austria
Prior art keywords
medium chain
long
triglycerids
patient
chain triglycerides
Prior art date
Application number
AT85901182T
Other languages
English (en)
Inventor
Richard Cotter
Robert C Johnson
Bruce W Rowe
Susan K Young
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24339526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE73996(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE73996T1 publication Critical patent/ATE73996T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT85901182T 1984-03-01 1985-02-05 Verwendung lang- und mittelkettiger triglyzeride. ATE73996T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/584,974 US4678807A (en) 1984-03-01 1984-03-01 Method for directed visceral metabolism of medium chain triglycerides
EP85901182A EP0172880B2 (de) 1984-03-01 1985-02-05 Verwendung lang- und mittelkettiger triglyzeride
PCT/US1985/000175 WO1985003863A1 (en) 1984-03-01 1985-02-05 Method for directed visceral metabolism of medium chain triglyce rides

Publications (1)

Publication Number Publication Date
ATE73996T1 true ATE73996T1 (de) 1992-04-15

Family

ID=24339526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85901182T ATE73996T1 (de) 1984-03-01 1985-02-05 Verwendung lang- und mittelkettiger triglyzeride.

Country Status (9)

Country Link
US (1) US4678807A (de)
EP (1) EP0172880B2 (de)
JP (1) JP2509810B2 (de)
AT (1) ATE73996T1 (de)
AU (1) AU574438B2 (de)
CA (1) CA1249523A (de)
DE (1) DE3585712D1 (de)
WO (1) WO1985003863A1 (de)
ZA (1) ZA851046B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
US5120306A (en) * 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5622991A (en) * 1994-08-30 1997-04-22 Cornell Research Foundation, Inc. Treating inflammatory liver disorders by enterally administering a fat-containing diet low in polyunsaturated fats
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US6835408B2 (en) 1998-11-13 2004-12-28 The Nisshin Oillio Group, Ltd. Oil or fat composition
DE10130491A1 (de) * 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
AU2003261927A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Peroxisome proliferator-activated receptor controllers
AU2003261926A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Slimming agents and foods and drinks comprising the same
JPWO2004022050A1 (ja) * 2002-09-05 2005-12-22 日清オイリオグループ株式会社 脂質代謝調整剤および飲食物
US7915977B2 (en) 2007-09-19 2011-03-29 Isotek Electronics Limited Tuneable bandpass filter
US7659220B1 (en) * 2008-12-03 2010-02-09 Osram Sylvania Inc. Sealing composition for sealing aluminum nitride and aluminum oxynitride ceramics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS537492B2 (de) * 1973-02-12 1978-03-18
US4423072A (en) * 1979-12-28 1983-12-27 The University Of Kentucky Research Foundation Method for improving the metabolic stability and survival of neonatal pigs
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
DE3131460A1 (de) * 1981-08-08 1983-02-24 B. Braun Melsungen Ag, 3508 Melsungen Fettemsulsion fuer parenterale ernaehrung
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
EP0092076B1 (de) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
AU580278B2 (en) * 1984-01-16 1989-01-12 Baxter International Inc. Treating liver diseases in patients by administering compositions of medium and long chain triglycerides
WO1985003002A1 (en) * 1984-01-16 1985-07-18 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides

Also Published As

Publication number Publication date
AU3935485A (en) 1985-09-24
CA1249523A (en) 1989-01-31
JPS61501322A (ja) 1986-07-03
AU574438B2 (en) 1988-07-07
EP0172880A4 (de) 1987-11-25
WO1985003863A1 (en) 1985-09-12
EP0172880A1 (de) 1986-03-05
JP2509810B2 (ja) 1996-06-26
EP0172880B2 (de) 1995-11-02
DE3585712D1 (de) 1992-04-30
EP0172880B1 (de) 1992-03-25
ZA851046B (en) 1985-09-25
US4678807A (en) 1987-07-07

Similar Documents

Publication Publication Date Title
ATE73996T1 (de) Verwendung lang- und mittelkettiger triglyzeride.
ATE73658T1 (de) Diaetzusatz zur verminderung der gefahr einer infektion.
KR880010763A (ko) 심장 및 심장혈관계에 작용하는 약학조성물 및 그의 제조방법
ATE152611T1 (de) Wasser in öl emulsion zur kosmetischen oder pharmazeutischen verwendung
DE69521338D1 (de) Öl-in-wasser-emulsionen
DE68901097D1 (de) Cycloalkylaminomethylenbisphosphonsaeuren und medikamente, die sie enthalten.
DK68080A (da) Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod
ES467222A1 (es) Procedimiento de preparacion de una emulsion del tipo agua en aceite o aceite en agua estable.
ATE105296T1 (de) Glycosylierte insulin-derivate.
ATE128352T1 (de) Diät zur besserem ueberleben von kranken mit sepsis.
DE3683337D1 (de) Essbare wasser-in-oel-emulsionen mit einem reduzierten fettgehalt und verwendung dieser emulsionen zur herstellung von baeckereiprodukten.
DK413288D0 (da) Lipid-holdig emulsion til enteral eller parenteral ernaering og farmaceutisk middel indeholdende en saadan emulsion
DE3770830D1 (de) Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
ATE74493T1 (de) Hitzesterilisierbare wasser-und-oel-emulsion.
ATE58063T1 (de) Verwendung von glycofurol zum verfluessigen von arzneimittelzubereitungen fuer das abfuellen in weichgelatinekapseln.
ATE20540T1 (de) Vollsynthetisches zellkulturmedium.
DK0380170T4 (da) Lactoproteinfri lav-kalorie smørerstatning med et fedtindhold på 20-60 vægt-% indeholdende gelatine og solubiliseret stivelse
ES2055248T3 (es) Estabilizacion de emulsiones de perfluorocarbono y compuestos heterociclicos perfluorados utilizables como adiciones estabilizadoras de emulsiones.
KR850700008A (ko) 의약용과 미용에 사용되는 조성물의 제조방법
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
PT89654A (pt) Processo para a preparacao de composicoes que contem gorduras com um baixo conteudo de fosfatidos
ES8308890A1 (es) Procedimiento para la preparacion de cetales de 3'-deshidro -cardenolido-tridigitoxosidos.
DE3672387D1 (de) Herstellung von zelladhaesioninhibitoren, so erhaltene antiadhaesine und diese enthaltende arzneimittel und naehrmittel.
KR890011901A (ko) 동물 성장 촉진제

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee